Medistep Healthcare IPO: Issue has so far discussed almost 5x on Day 1; GMP Signals 35% List Profits – Check Other Key Details

Medistep Healthcare IPO: The Initial Public Offer (IPO) of Medistep Healthcare kicked off on Friday, August 8. The edition passed within a few hours on the first day of the bid process amid a solid gray market premium (GMP). Medistep Healthcare IPO will remain open until Tuesday, August 12 to bid. The individual investor portion was discussed 7.84 times and the non-institutional copper section was discussed 1.40 times. In general, the Medistep Healthcare IPO received bid for 1.64 crore shares, compared to 35.55 Lakh shares offered. Medistep Healthcare IPO GMP Medistep Healthcare IPO GMP Today is £ 15. Although slightly lower than £ 17, it is still a strong listing premium. At the prevailing GMP and the edition price of £ 43 each, Medistep Healthcare IPO list price could be £ 58, which is an indication of a 34.88% profit on the debut of the stock market. Medistep Healthcare IPO Details The SME scholarship of Medistep Healthcare is a fixed awards edition of £ 16 crore. This is entirely a new issue of 37.44 Lakh shares at £ 43 each. Investors can apply for the Medistep Healthcare IPO in many 3000 shares. Retail investors must apply for at least 6,000 shares, which require an investment of £ 2,58,000. The company plans to use the funds to finance capital expenditure for the purchase of plant and machinery for expansion at the existing manufacturing facility, to the needs of the working capital and for general corporate purposes. After closing the bursary trading on August 12, the Medistep Healthcare IPO award will be finalized on August 13. Meanwhile, Medistep Healthcare IPO list is expected to take place on NSE SME. The general manager of the Medistep Healthcare IPO, while Cameo Corporate Services is limited, will be the book manager of the Medistep Healthcare IPO. Medistep Healthcare works in the pharmaceutical sector and is involved in the trading of pharmaceutical products, intimate care and hygiene products, surgical products and nutritional products and production of intimate and nutritional products. Disclaimer: This story is for educational purposes only. The views and recommendations expressed are those of individual analysts or brokerage firms, not coin. We advise investors to consult with certified experts before making investment decisions, as market conditions can change quickly and conditions can vary.